R. J. Sullivan and K. Flaherty, MAP kinase signaling and inhibition in melanoma, Oncogene, vol.32, pp.2373-2379, 2013.

T. Lapidot, C. Sirard, J. Vormoor, B. Murdoch, T. Hoang et al., A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, vol.367, issue.6464, pp.645-648, 1994.

S. K. Singh, C. Hawkins, I. D. Clarke, J. A. Squire, J. Bayani et al., Identification of human brain tumour initiating cells, Nature, vol.432, issue.7015, pp.396-401, 2004.

L. Ricci-vitiani, D. G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro et al., Identification and expansion of human colon-cancer-initiating cells, Nature, vol.445, issue.7123, pp.111-115, 2007.

T. Schatton, G. F. Murphy, N. Y. Frank, K. Yamaura, A. M. Waaga-gasser et al., Identification of cells initiating human melanomas, Nature, vol.451, issue.7176, pp.345-349, 2008.

A. D. Boiko, O. V. Razorenova, M. Van-de-rijn, S. M. Swetter, D. L. Johnson et al., Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, vol.466, issue.7302, pp.133-137, 2010.

Y. Cheli, S. Giuliano, N. Fenouille, A. M. Hofman, V. Hofman et al., Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells, Oncogene, vol.31, pp.2461-2470, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02530643

K. S. Hoek and C. R. Goding, Cancer stem cells versus phenotype-switching in melanoma. Pigment cell & melanoma research, vol.23, pp.746-759, 2010.

Y. Cheli, S. Guiliano, T. Botton, S. Rocchi, V. Hofman et al., Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny, Oncogene, vol.30, issue.20, pp.2307-2318, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530763

W. Liu, K. B. Monahan, A. D. Pfefferle, T. Shimamura, J. Sorrentino et al., LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma, Cancer Cell, vol.21, issue.6, pp.751-764, 2012.

Y. Luo, K. Dallaglio, Y. Chen, W. A. Robinson, S. E. Robinson et al., ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets, Stem Cells, vol.30, issue.10, pp.2100-2113, 2012.

A. Roesch, M. Fukunaga-kalabis, E. C. Schmidt, S. E. Zabierowski, P. A. Brafford et al., A temporarily distinct subpopulation of slowcycling melanoma cells is required for continuous tumor growth, Cell, vol.141, issue.4, pp.583-594, 2010.

Y. Cheli, S. Giuliano, T. Botton, S. Rocchi, V. Hofman et al., Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny, Oncogene, vol.30, issue.20, pp.2307-2318, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-02530763

S. Carreira, J. Goodall, L. Denat, M. Rodriguez, P. Nuciforo et al., Mitf regulation of Dia1 controls melanoma proliferation and invasiveness, Genes Dev, vol.20, issue.24, pp.3426-3439, 2006.

S. J. Morrison, P. M. White, C. Zock, and A. Dj, Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells, Cell, vol.96, issue.5, pp.737-749, 1999.

G. Civenni, A. Walter, N. Kobert, D. Mihic-probst, M. Zipser et al., Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth, Cancer research, vol.71, issue.8, pp.3098-3109, 2011.

K. G. Chen, J. C. Valencia, J. P. Gillet, V. J. Hearing, and M. M. Gottesman, Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma. Pigment cell & melanoma research, vol.22, pp.740-749, 2009.

N. Y. Frank, A. Margaryan, Y. Huang, T. Schatton, A. M. Waaga-gasser et al., ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma, Cancer research, vol.65, issue.10, pp.4320-4333, 2005.

E. Quintana, M. Shackleton, H. R. Foster, D. R. Fullen, M. S. Sabel et al., Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized, Cancer Cell, vol.18, issue.5, pp.510-523, 2010.

P. Bahadoran, A. M. , L. Duff, F. Long-mira, E. Hofman et al., Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.31, pp.324-326, 2013.

S. A. Mani, W. Guo, M. J. Liao, E. N. Eaton, A. Ayyanan et al., The epithelialmesenchymal transition generates cells with properties of stem cells, Cell, vol.133, issue.4, pp.704-715, 2008.

D. Bonnet and J. E. Dick, Human acute myeloid leukemia is www.impactjournals.com/oncotarget organized as a hierarchy that originates from a primitive hematopoietic cell, Nature medicine, vol.3, issue.7, pp.730-737, 1997.

P. B. Gupta, C. M. Fillmore, G. Jiang, S. D. Shapira, K. Tao et al., Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells, Cell, vol.146, issue.4, pp.633-644, 2011.

M. V. Blagosklonny, Cancer stem cell and cancer stemloids: from biology to therapy, Cancer Biol Ther, vol.6, issue.11, pp.1684-1690, 2007.

M. V. Blagosklonny, Target for cancer therapy: proliferating cells or stem cells, Leukemia, vol.20, issue.3, pp.385-391, 2006.

U. Testa, Leukemia stem cells, Ann Hematol, vol.90, issue.3, pp.245-271, 2011.

W. A. Woodward and E. P. Sulman, Cancer stem cells: markers or biomarkers?, Cancer Metastasis Rev, vol.27, issue.3, pp.459-470, 2008.

L. Prestegarden, A. Svendsen, J. Wang, L. Sleire, K. O. Skaftnesmo et al., Glioma cell populations grouped by different cell type markers drive brain tumor growth, Cancer research, vol.70, issue.11, pp.4274-4279, 2010.

M. Al-hajj, M. S. Wicha, A. Benito-hernandez, S. J. Morrison, and M. F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proceedings of the National Academy of Sciences of the United States of America, vol.100, issue.7, pp.3983-3988, 2003.

C. Bertolotto, F. Lesueur, S. Giuliano, T. Strub, M. De-lichy et al., A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, issue.7375, pp.94-98, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01791271

A. De-luca, L. Lamura, L. Strizzi, C. Roma, D. Antonio et al., Expression and functional role of CRIPTO-1 in cutaneous melanoma, Br J Cancer, vol.105, issue.7, pp.1030-1038, 2011.

L. Strizzi, D. E. Abbott, S. Ds, and M. J. Hendrix, Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma, Cell Cycle, vol.7, issue.13, pp.1931-1935, 2008.

L. Strizzi, N. V. Margaryan, A. Gilgur, K. M. Hardy, N. Normanno et al., The significance of a Cripto-1 positive subpopulation of human melanoma cells exhibiting stem cell-like characteristics, Cell Cycle, vol.12, issue.9, pp.1450-1456, 2013.

D. Besser, Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. The Journal of biological chemistry, vol.279, pp.45076-45084, 2004.

T. Nagaoka, H. Karasawa, T. Turbyville, M. C. Rangel, N. P. Castro et al., Cripto-1 enhances the canonical Wnt/beta-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors, Cell Signal, vol.25, issue.1, pp.178-189, 2013.

X. Liu, M. Luo, W. Xie, J. M. Wells, M. J. Goodheart et al., Sox17 modulates Wnt3A/beta-cateninmediated transcriptional activation of the Lef-1 promoter, Am J Physiol Lung Cell Mol Physiol, vol.299, issue.5, pp.694-710, 2010.

L. J. Chew, W. Shen, X. Ming, V. V. Senatorov, J. Chen et al., SRY-box containing gene 17 regulates the Wnt/beta-catenin signaling pathway in oligodendrocyte progenitor cells, J Neurosci, vol.31, issue.39, pp.13921-13935, 2011.

H. L. Chen, L. J. Chew, R. J. Packer, and V. Gallo, Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation, Cancer Lett, vol.335, issue.2, pp.361-371, 2013.

P. Andreu, S. Colnot, C. Godard, P. Laurent-puig, D. Lamarque et al., Identification of the IFITM family as a new molecular marker in human colorectal tumors, Cancer research, vol.66, issue.4, pp.1949-1955, 2006.

J. D. Holland, A. Klaus, A. N. Garratt, and W. Birchmeier, Wnt signaling in stem and cancer stem cells, Curr Opin Cell Biol, vol.25, issue.2, pp.254-264, 2013.

L. Larue and V. Delmas, The WNT/Beta-catenin pathway in melanoma, Front Biosci, vol.11, pp.733-742, 2006.

P. Wan, Y. Hu, and L. He, Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors, Mol Cell Biochem, vol.354, issue.1-2, pp.241-246, 2011.

F. Vaillant, M. L. Asselin-labat, M. Shackleton, G. J. Lindeman, and J. E. Visvader, The emerging picture of the mouse mammary stem cell, Stem Cell Rev, vol.3, issue.2, pp.114-123, 2007.

G. B. Pierce, Neoplasms, differentiations and mutations, Am J Pathol, vol.77, issue.1, pp.103-118, 1974.

S. Yokoyama, S. L. Woods, G. M. Boyle, L. G. Aoude, S. Macgregor et al., A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, issue.7375, pp.99-103, 2011.

K. C. Mansky, U. Sankar, H. J. Ostrowski, and M. C. , Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling, The Journal of biological chemistry, vol.277, issue.13, pp.11077-11083, 2002.

A. Galy, B. Neron, N. Planque, S. Saule, and A. Eychene, Activated MAPK/ERK kinase (MEK-1) induces transdifferentiation of pigmented epithelium into neural retina, Dev Biol, vol.248, issue.2, pp.251-264, 2002.

R. Kumar, S. Angelini, E. Snellman, and K. Hemminki, BRAF mutations are common somatic events in melanocytic nevi, J Invest Dermatol, vol.122, issue.2, pp.342-348, 2004.

H. Gear, H. Williams, E. G. Kemp, and F. Roberts, BRAF mutations in conjunctival melanoma, Invest Ophthalmol Vis Sci, vol.45, issue.8, pp.2484-2488, 2004.

M. Khaled, L. Larribere, K. Bille, E. Aberdam, and J. P. Ortonne,

R. Ballotti and C. Bertolotto, Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis, The Journal of biological chemistry, vol.277, issue.37, pp.33690-33697, 2002.

P. Guldberg, P. Thor-straten, A. Birck, V. Ahrenkiel, A. F. Kirkin et al., Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma, Cancer research, vol.57, issue.17, pp.3660-3663, 1997.

M. Ohanna, Y. Cheli, C. Bonet, V. F. Bonazzi, A. M. Giuliano et al., Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumorinitiating cell phenotype, Oncotarget, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-02530603